These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33545668)

  • 41. Characterization of young people with first episode psychosis or at ultra-high risk: the Reggio Emilia At-Risk Mental States (ReARMS) program.
    Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Poletti M; Pupo S; Raballo A
    Riv Psichiatr; 2019; 54(6):254-263. PubMed ID: 31909752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.
    Yung AR; Stanford C; Cosgrave E; Killackey E; Phillips L; Nelson B; McGorry PD
    Schizophr Res; 2006 May; 84(1):57-66. PubMed ID: 16630707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.
    Preti A; Cella M
    Schizophr Res; 2010 Oct; 123(1):30-6. PubMed ID: 20727717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A network meta-analysis of psychological interventions for schizophrenia and psychosis: Impact on symptoms.
    Mc Glanaghy E; Turner D; Davis GA; Sharpe H; Dougall N; Morris P; Prentice W; Hutton P
    Schizophr Res; 2021 Feb; 228():447-459. PubMed ID: 33578368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.
    Markulev C; McGorry PD; Nelson B; Yuen HP; Schaefer M; Yung AR; Thompson A; Berger G; Mossaheb N; Schlögelhofer M; Smesny S; de Haan L; Riecher-Rössler A; Nordentoft M; Chen EYH; Verma S; Hickie I; Amminger GP
    Early Interv Psychiatry; 2017 Oct; 11(5):418-428. PubMed ID: 26279065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical profile, conversion rate, and suicidal thinking and behaviour in children and adolescents at ultra-high risk for psychosis: a theoretical perspective.
    Pontillo M; Tata MC; Averna R; Gargiullo P; Guerrera S; Vicari S
    Res Psychother; 2020 May; 23(1):455. PubMed ID: 32913830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis.
    Liu P; Parker AG; Hetrick SE; Callahan P; de Silva S; Purcell R
    Schizophr Res; 2010 Oct; 123(1):37-44. PubMed ID: 20558043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research and practice for ultra-high risk for psychosis: A national survey of early intervention in psychosis services in England.
    Stain HJ; Mawn L; Common S; Pilton M; Thompson A
    Early Interv Psychiatry; 2019 Feb; 13(1):47-52. PubMed ID: 28612979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early Detection of Ultra High Risk for Psychosis in a Norwegian Catchment Area: The Two Year Follow-Up of the Prevention of Psychosis Study.
    Joa I; Bjornestad J; Johannessen JO; Langeveld J; Stain HJ; Weibell M; Hegelstad WTV
    Front Psychiatry; 2021; 12():573905. PubMed ID: 33716805
    [No Abstract]   [Full Text] [Related]  

  • 54. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
    Schmidt SJ; Hurlemann R; Schultz J; Wasserthal S; Kloss C; Maier W; Meyer-Lindenberg A; Hellmich M; Muthesius-Digón A; Pantel T; Wiesner PS; Klosterkötter J; Ruhrmann S;
    Early Interv Psychiatry; 2019 Dec; 13(6):1404-1415. PubMed ID: 30784233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
    de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
    Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ
    Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can clinicians predict psychosis in an ultra high risk group?
    Nelson B; Yung AR
    Aust N Z J Psychiatry; 2010 Jul; 44(7):625-30. PubMed ID: 20397780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.